Lopinavir/ritonavir: repurposing an old drug for HIV infection in COVID-19 treatment

Currently, there is no specific antiviral treatment for COVID-19. However, drugs previously developed to treat other viral infections are being tested to verify if they might also be effective against SARS-CoV-2, the virus that causes COVID-19. Twenty years ago, the F.D.A. approved Lopinavir/ritonav...

Full description

Autores:

Tipo de recurso:

Article of investigation

Fecha de publicación:

2020

Institución:

Universidad de Bogotá Jorge Tadeo Lozano

Repositorio:

Expeditio: repositorio UTadeo

Idioma:

eng

OAI Identifier:

oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/15594

Acceso en línea:

https://doi.org/10.1016/j.bj.2020.11.005
http://hdl.handle.net/20.500.12010/15594

Palabra clave:

Lopinavir
Ritonavir
Protease inhibitor
SARS-CoV-2
COVID-19 treatment
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus

Rights

License

Abierto (Texto Completo)